Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca Sells off Seroquel Rights in U.S. and Canada
BioSpace
Tue, 12/3/19 - 10:44 pm
Tags:
AstraZeneca, Cheplapharm, Seroquel, Seroquel XR, bipolar disorder, schizophrenia
'Positive surprise' for Biogen in lupus, but all eyes on CTAD data this week
Fierce Biotech
Tue, 12/3/19 - 10:20 pm
Tags:
Biogen, AstraZeneca, lupus, Amgen clinical trials, BIIB059
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Fierce Pharma
Tue, 12/3/19 - 09:50 am
Tags:
AstraZeneca, diabetes, type 2 diabetes, heart failure
AstraZeneca, Novoheart to Co-Develop New Heart Model
Xconomy
Wed, 11/27/19 - 10:40 am
Tags:
AstraZeneca, Novoheart, heart-in-a-jar, heart failure
[release] eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists
CP Wire
Mon, 11/25/19 - 01:02 pm
Tags:
cloud platforms, commercialization, training, sales reps, ACTO, AstraZeneca
AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
BioSpace
Mon, 11/25/19 - 09:46 am
Tags:
AstraZeneca, FDA, CLL, SLL, Calquence
AstraZeneca CEO: Closing In On A Cancer Cure
Yahoo/Benzinga
Sat, 11/23/19 - 04:20 pm
Tags:
AstraZeneca, Pascal Soriot, oncology, cancer
AstraZeneca's Calquence steps up to challenge Imbruvica with big CLL green light
Fierce Pharma
Thu, 11/21/19 - 06:26 pm
Tags:
AstraZeneca, Calquence, Imbruvica, CLL, JNJ, AbbVie
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
Fierce Pharma
Tue, 11/19/19 - 11:38 pm
Tags:
earnings, Big Pharma, AstraZeneca, Merck, Celgene, Novartis, Novo Nordisk, Pfizer
AHA: AstraZeneca's Brilinta linked to less bleeding solo than as an aspirin add-on
Fierce Pharma
Sun, 11/17/19 - 08:35 pm
Tags:
AstraZeneca, Brilinta, Farxiga, AHA
AHA: AstraZeneca's Farxiga outcomes data looks even better in patients without diabetes
Fierce Pharma
Sat, 11/16/19 - 10:42 pm
Tags:
AstraZeneca, Farxiga, diabetes
AstraZeneca, Merck win red carpet treatment at the FDA as a 3-time loser seeks speedy OK for rare tumors
Endpoints
Thu, 11/14/19 - 10:21 am
Tags:
AstraZeneca, Merck, selumetinib, cancer
AstraZeneca plans 2020 filing for anifrolumab in lupus
Fierce Biotech
Tue, 11/12/19 - 10:25 am
Tags:
AstraZeneca, FDA, lupus, anifrolumab
Data From 3 Roxadustat Trials Lead Off Kidney Week Sessions Ahead of Efficacy, Safety News
Managed Markets Network
Sat, 11/9/19 - 12:12 pm
Tags:
nephrology, roxadustat, AstraZeneca, FibroGen, kidney disease
Top execs from AstraZeneca, Roche, Sanofi and GSK tout China investments at import expo
Fierce Pharma
Thu, 11/7/19 - 10:21 am
Tags:
China, AstraZeneca, Roche, Sanofi, GSK
AstraZeneca creates $1B Chinese fund, vows to double R&D team
Fierce Biotech
Wed, 11/6/19 - 10:38 am
Tags:
AstraZeneca, China, R&D
Daiichi Sankyo takes Seattle Genetics to court as battle over breast cancer drug escalates
Pharmaforum
Wed, 11/6/19 - 10:18 am
Tags:
Daiichi Sankyo, Seattle Genetics, breast cancer, AstraZeneca, trastuzumab deruxtecan, Herceptin
Daiichi sues Seattle Genetics over tech used in high-profile ADC
Fierce Biotech
Tue, 11/5/19 - 10:34 am
Tags:
Daiichi Sankyo, Seattle Genetics, antibody-drug conjugate, AstraZeneca, DS-8201
AstraZeneca tops first Pharmaceutical Invention Index
Pharma Letter
Mon, 11/4/19 - 10:04 am
Tags:
AstraZeneca, R&D
Is AbbVie's Imbruvica concerned about AZ's rising Calquence? We've got this covered, execs say
Fierce Pharma
Fri, 11/1/19 - 06:55 pm
Tags:
AbbVie, Rinvoq, AstraZeneca, Calquence, Imbruvica

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.